Eledon Pharmaceuticals, Inc. (ELDN)
2.19
-0.03
(-1.35%)
USD |
NASDAQ |
Feb 20, 16:00
2.18
-0.01
(-0.46%)
After-Hours: 20:00
Eledon Pharmaceuticals EPS Diluted (Quarterly) : -0.2263 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | -0.0087 |
| Viking Therapeutics, Inc. | -1.383 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.46M |
| Total Expenses (Quarterly) | 17.46M |
| Enterprise Value | 137.41M |
| Earnings Yield | -54.89% |
| Normalized Earnings Yield | -53.20 |